# Mohamed Batterjee

> Dr. Mohamed Mazen Batterjee is the Co-Founder, CCO, and investor behind Aumet, an AI-first procurement operating system reshaping pharmaceutical supply chains across the Middle East. A scion of one of Saudi Arabia's oldest pharma dynasties, he parlayed a DBA from IE Business School and 15+ years running Batterjee Pharmaceuticals into co-founding a platform that now connects 12,000+ pharmacies, 1,000+ suppliers, and has processed over $1 billion in GMV. Aumet closed a $12M Series A in May 2026, bringing total funding to $21.84M.

- **Role:** Co-Founder & CCO at Aumet
- **Organizations:** Aumet inc, Batterjee Pharmaceuticals
- **From:** Jeddah, Saudi Arabia
- **Nationality:** Saudi Arabian
- **Education:** Bachelor's degree, Strathclyde University, Scotland, UK, Master of Business Administration (MBA), Strathclyde University, Scotland, UK, Master's degree, IE University (IE Business School), Madrid, Spain, Doctorate in Business Administration (DBA) - specialization in entrepreneurship in family businesses, IE University (IE Business School), Madrid, Spain
- **Known for:** Named Forbes Middle East Top 100 Healthcare Leaders (2023), Co-founded Aumet, now serving 12,000+ pharmacies across 5 countries, Led Aumet's Saudi Arabia expansion, the platform's largest market

## Career timeline

- **Late 1940s (family)** — Batterjee family begins importing international pharmaceuticals and establishing pharmacy chains in Saudi Arabia
- **2006-2007** — Completes MBA at Strathclyde University, Scotland, on Saudi Aramco scholarship
- **2007** — Joins Saudi Aramco following MBA graduation
- **2007** — Joins family business Batterjee Pharmaceuticals as Managing Director/CEO
- **2012** — Begins Doctorate in Business Administration at IE University, Madrid
- **2016** — Aumet founded by Yahya Aqel, Adel Haddad, and Shahed Jaber; Batterjee begins investing and advising
- **2020** — Completes DBA at IE University; becomes formal Co-Founder, CCO, and investor at Aumet
- **2021** — Aumet raises Seed round of $1.25M; acquires Unidor (Jordan)
- **2023** — Aumet raises $7M Pre-Series A; named Forbes Middle East Top 100 Healthcare Leader
- **2024** — Aumet expands to 5 MENA countries; crosses $1B GMV milestone
- **2026-05** — Aumet closes $12M Series A led by Emkan Capital; total raised reaches $21.84M

## Achievements

- Named Forbes Middle East Top 100 Healthcare Leaders (2023)
- Co-founded Aumet, now serving 12,000+ pharmacies across 5 countries
- Led Aumet's Saudi Arabia expansion, the platform's largest market
- Helped Aumet cross $1 billion in gross merchandise value
- Secured Aumet's $12M Series A from investors including Qatar Development Bank and SABAH VC
- Turned around Batterjee Pharmaceuticals, a family company that had suffered 10 years of losses
- Active angel investor in tech companies globally

## Latest updates

- **2026-05** — Aumet closes $12M Series A led by Emkan Capital with participation from Qatar Development Bank, SABAH VC, AAIC, Shorooq Partners, and strategic investors Cigalah Group and Salehiya Trading Company
- **2026-05** — Total funding reaches $21.84M; Aumet targets expansion to 20 markets by 2027
- **2024-06** — Interview published on DH Arab discussing Aumet's growth strategy and sustainable profitability approach
- **2023** — Named Forbes Middle East Top 100 Healthcare Leader

## Links

- Website: https://aumet.com
- LinkedIn: http://www.linkedin.com/in/mohamed-mazen-batterjee-b67a572b
- Twitter/X: https://twitter.com/aumet_me
- YouTube: https://www.youtube.com/watch?v=UU9YIOXnO-Q
- Facebook: https://www.facebook.com/aumet.me/?fref=ts

---

Profile page: https://yespress.io/mohamed-batterjee
Published by YesPress — https://yespress.io
Last updated: 2026-05-25